Provided by Tiger Fintech (Singapore) Pte. Ltd.

Poseida Therapeutics, Inc.

9.50
0.0000
Volume:- -
Turnover:203.93M
Market Cap:928.85M
PE:-14.95
High:9.50
Open:9.50
Low:9.50
Close:9.50
Loading ...

Roche to Acquire CAR-T Cell Therapy Focused Poseida for $1.5B

Zacks
·
26 Nov 2024

Trending: Roche to Buy Poseida Therapeutics for Up to $1.5 Billion

Dow Jones
·
26 Nov 2024

Poseida Therapeutics Up Nearly 225%, On Pace For Record High Close -- Data Talk

Dow Jones
·
26 Nov 2024

Stock Track | Poseida Therapeutics Soars 224.65% As Roche's $1.5 Billion Acquisition Bolsters Cell Therapy Capabilities

Stock Track
·
26 Nov 2024

Poseida Therapeutics Surges 224% As Roche to Acquire the US Firm in $1.5 Bln Deal

Reuters
·
26 Nov 2024

Poseida Therapeutics Shares Surge 225% After Roche to Acquire Co in $1.5 Bln Deal

THOMSON REUTERS
·
26 Nov 2024

Poseida Therapeutics Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
26 Nov 2024

Sector Update: Health Care Stocks Mixed Premarket Tuesday

MT Newswires Live
·
26 Nov 2024

Roche's Proposed Acquisition Of Poseida Therapeutics Poised To Establish New Core Capability In Cell Therapy For Cancer And Autoimmune Diseases: Details

Benzinga
·
26 Nov 2024

Poseida Therapeutics, Inc. : H.c. Wainwright Cuts to Neutral From Buy

THOMSON REUTERS
·
26 Nov 2024

Poseida Therapeutics downgraded to Neutral from Buy at H.C. Wainwright

TIPRANKS
·
26 Nov 2024

Poseida downgraded to Market Perform from Outperform at William Blair

TIPRANKS
·
26 Nov 2024

Traders Eye Fed Minutes, Driving Muted Premarket Action for US Equity Futures

MT Newswires Live
·
26 Nov 2024

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Tuesday Ahead of FOMC Meeting Minutes

MT Newswires Live
·
26 Nov 2024

Poseida Therapeutics Inc : Btig Cuts to Neutral From Buy

THOMSON REUTERS
·
26 Nov 2024

William Blair downgrades Poseida Therapeutics (PSTX) to a Hold

TIPRANKS
·
26 Nov 2024

BRIEF-Poseida Therapeutics To Pay Roche Holdings Termination Fee Of $33.42 Million If Deal Is Terminated Under Certain Conditions

Reuters
·
26 Nov 2024

Poseida Therapeutics : to Pay Roche Holdings, Termination Fee of $33.42 Mln IF Deal Is Terminated Under Certain Conditions

THOMSON REUTERS
·
26 Nov 2024

Poseida Therapeutics downgraded to Neutral from Buy at BTIG

TIPRANKS
·
26 Nov 2024